logo
15:58 May 29

Syncom Formulation (India) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
15.01
-0.59 (-3.78%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Syncom Formulation (India) Ltd. Financials

Syncom Formulation (India) Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
15.01
-0.59 (-3.78%)
15:58 May 29
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

55/100
Technically Neutral

Strength

16

Weakness

1

Opportunity

0

Threats

0

18.41 %

ROE %

14.31 %

ROA %

0.81

EPS

4.41

BVPS

15.62 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
219.66 224.25 263.39 465.01 489.17
Operating Expenses +
199.62 204.62 233.75 410.89 411.74
Raw Material
137.22 142.07 158.64 318 288.17
Increase Decrease in Cost
3.32 -0.38 -1.75 -10.66 -3.89
Other Manufacturing Expense
6.31 8.15 8.12 8.1 0
Employee Cost
22.16 25.87 35.06 52.17 67.09
Miscellaneous Expenses
110.23 114.13 87.9 123.22 194.83
Operating Profit
20.04 19.63 29.64 54.12 77.43
Other Income
11.99 14.6 13.53 17.43 31.34
Depreciation
3.95 4.54 4.72 5.19 6.53
Interest
1.93 3.13 4.47 0.86 1.16
Profit before tax and exceptio..
26.15 26.56 33.98 65.51 101.08
Exceptional Items
0.02 0.01 -0.02 0.01 0.04
PBT
26.18 26.57 33.95 65.51 101.12
Provision for Taxation
6.39 6.5 8.64 16.08 24.68
Net Profit
19.79 20.07 25.31 49.43 76.44
NET Profit after MI
19.79 20.07 25.31 49.43 76.44
EPS
0.26 0.24 0.34 0.57 0.81
Operating Profit Margin (%)
9.12 8.75 11.25 11.64 15.83
Net Profit Margin (%)
9.01 8.95 9.61 10.63 15.63

Syncom Formulation (India) Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 50.60 50.60 50.60 50.60 50.60 50.60
FII 0.20 0.30 0.10 0.40 0.10 0.10
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 49.20 49.10 49.30 49.00 49.30 49.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: